PYY and the pancreas: Inhibition of tumor growth and inflammation

Peptides

Volumn 28, Issue 2, 2007, Pages 334-338

  Vona Davis, Linda ^a   McFadden, David W ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amylase; Cancer; Cytokines; Pancreatitis; Peptide YY; PYY; PYY analogs; Transcription factors

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; AMYLASE; BIM 43004 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; FOLINIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR AGONIST; PEPTIDE YY; PEPTIDE YY [14-36]; PEPTIDE YY [22-36]; PEPTIDE YY [3-16]; PROTEIN P53; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; SYNTHETIC PEPTIDE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACINAR CELL; AMYLASE RELEASE; CANCER INHIBITION; CYTOKINE RELEASE; DIGESTION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; GASTROINTESTINAL ABSORPTION; GROWTH REGULATION; HUMAN; NONHUMAN; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CELL DIVISION; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS; PEPTIDE YY;

EID: 33846579716     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.033     Document Type: Review

References (26)

1. Balasubramaniam A., Tao Z., Zhai W., Stein M., Sheriff S., Chance W.T., et al. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine. J Med Chem 43 (2000) 3420-3427
2. Bilchik A.J., Hines O.J., Adrian T.E., McFadden D.W., Berger J.J., Zinner M.J., et al. Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo. Gastroenterology 105 (1993) 1441-1448
3. Brodish R.J., Kuvshinoff B.W., Fink A.S., and McFadden D.W. Peptide YY inhibits pancreatic secretion via cholinergic pathways. J Surg Res 55 (1993) 103-108
4. Brodish R.J., Kuvshinoff B.W., McFadden D.W., and Fink A.S. Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion. Pancreas 10 (1995) 187-193
5. Gallmeier E., Schafer C., Moubarak P., Tietz A., Plossl I., Huss R., et al. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. J Cell Physiol 203 (2005) 209-216
6. Greten F.R., Weber C.K., Greten T.F., Schneider G., Wagner M., Adler G., et al. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 123 (2002) 2052-2063
7. Grise K.R., and McFadden D.W. Peptide YY improves local and systemic parameters and prevents death in lethal necrotizing pancreatitis. Pancreas 24 (2002) 90-95
8. Grise K.R., Rongione A.J., Laird E.C., and McFadden D.W. Peptide YY inhibits growth of human breast cancer in vitro and in vivo. J Surg Res 82 (1999) 151-155
9. Gukovskaya A.S., Gukovsky I., Zaninovic V., Song M., Sandoval D., Gukovsky S., et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100 (1997) 1853-1862
10. Gukovsky I., Gukovskaya A.S., Blinman T.A., Zaninovic V., and Pandol S.J. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275 (1998) G1402-G1414
11. Heisler T., Towfigh S., Simon N., McFadden D.W., and Peptide Y.Y. Vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells. J Surg Res 91 (2000) 9-14
12. Kazanjian K.K., Towfigh S., and McFadden D.W. Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro. J Surg Res 114 (2003) 95-99
13. Liu C.D., Balasubramaniam A., Saxton R.E., Paiva M., and McFadden D.W. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J Surg Res 58 (1995) 707-712
14. Liu C.D., Hines O.J., Whang E.E., Balasubramaniam A., Newton T.R., Zinner M.J., et al. A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive. J Surg Res 59 (1995) 80-84
15. Liu C.D., Hines O.J., Whang E.E., Laird E.C., Skotzko M.J., Zinner M.J., et al. Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection. J Surg Res 58 (1995) 6-11
16. Liu C.D., Kwan D., Simon N., and McFadden D.W. Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells. J Gastrointest Surg 5 (2001) 147-152
17. Liu C.D., Rongione A.J., Garvey L., Balasubramaniam A., and McFadden D.W. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth. Am J Surg 171 (1996) 192-196
18. Liu C.D., Slice L.W., Balasubramaniam A., Walsh J.H., Newton T.R., Saxton R.E., et al. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery 118 (1995) 229-235
19. McFadden D.W., Riggs D.R., Jackson B.J., and Vona-Davis L. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro. Am J Surg 188 (2004) 516-519
20. Rizvi I., Robinson K.S., McFadden D.W., Riggs D., Jackson B., and Vona-Davis L. Peptide YY reverses TNF-alpha induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells. J Surg Res 130 (2006) 171
21. Robinson K.S., Vona-Davis L., Riggs D., Jackson B., and McFadden D.W. Peptide YY attentuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J. J Am Coll Surg 202 (2006) 788-796
22. Satoh A., Gukovskaya A.S., Edderkaoui M., Daghighian M.S., Reeve Jr. J.R., Shimosegawa T., et al. Tumor necrosis factor-alpha mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosine kinase 2. Gastroenterology 129 (2005) 639-651
23. Steinle A.U., Weidenbach H., Wagner M., Adler G., and Schmid R.M. NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology 116 (1999) 420-430
24. Vona-Davis L., Yu A., Magabo K., Evans T., Jackson B., Riggs D., et al. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis. J Am Coll Surg 199 (2004) 87-95
25. Whang E.E., Hines O.J., Reeve Jr. J.R., Grandt D., Moser J.A., Bilchik A.J., et al. Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis Sci 42 (1997) 1121-1127
26. Yu A., Somasundar P., Balasubramaniam A., Rose A.T., Vona-Davis L., and McFadden D.W. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. J Surg Res 105 (2002) 65-68